US 2011/0028454 A1 · DEUTERIUM-ENRICHED BAZEDOXIFENE

Abstract

The present application describes deuterium-enriched bazedoxifene, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.

Claims20

Dependent claims

A deuterium-enriched compound of formula I or a pharmaceutically acceptable salt thereof:

wherein R1-R34 are independently selected from H and D;
and
the abundance of deuterium in Formula I is at least 3%.

Dependencies are inferred from the claim text.

Facts

Application

12/795,645Filed 7 Jun 2010

Priority

17 Sep 2007

Published

3 Feb 2011

Term ends

Not estimatedThe source records don’t support an estimate.

Classification10 codes

C07C 211/23
Of an acyclic unsaturated carbon skeleton: the carbon skeleton containing carbon-to-carbon triple bonds
A61P 19/00
Drugs for skeletal disorders
A61P 19/10
For bone diseases, e.g. rachitism, Paget's disease: for osteoporosis
C07B 59/002
Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se: heterocyclic compounds

Abstract

The present application describes deuterium-enriched bazedoxifene, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.

Claims20

Dependent claims

A deuterium-enriched compound of formula I or a pharmaceutically acceptable salt thereof:

wherein R1-R34 are independently selected from H and D;
and
the abundance of deuterium in Formula I is at least 3%.

Dependencies are inferred from the claim text.

Deuterium-enriched bazedoxifene

Life of this patent

Abstract

Claims20

Deuterium-enriched bazedoxifene

Life of this patent

Abstract

Claims20